Somnoware announced today that the company is launching a program to monitor and assist in the clinical triage of patients impacted by the Philips Respironics device recall. The program will be deployed in collaboration with Kaiser Permanente. Somnoware’s partnership...
Filling key sleep lab positions, increasing therapy adherence, reimbursement, bringing on the right technology—this is what’s on the minds of sleep medicine professionals in an increasingly difficult-to-navigate sleep medicine landscape. Getting the right answers...
A study involving patients with obstructive sleep apnea (OSA) and coronary artery disease (CAD) found that the physiological traits that cause OSA, including lower arousal threshold and both high and low pharyngeal muscle compensation, also influence CPAP adherence....
